This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Accelrys Honors Sanofi With Inaugural Scientific Innovation Lifecycle Leaders Award

Stocks in this article: ACCL

PARIS and SAN DIEGO, June 12, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced that it has honored Sanofi-Aventis Recherche & Developpement (hereinafter "Sanofi") with the first Accelrys Scientific Innovation Lifecycle Leaders Award. The award, in the Life Sciences Research and Development category, recognizes Sanofi's Share Drug Discovery Data with External Partners (SHERPA) service, which is dramatically accelerating Sanofi's collaboration with external partners, addressing a key obstacle to bringing innovative new products to market faster and more efficiently.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/accelrys-honors-sanofi-with-inaugural-scientific-innovation-lifecycle-leaders-award-211233271.html

The award was accepted by Marie-Pierre Fialon, Data Manager Sanofi R&D, Yves Collenot, Project Manager Informatics & Solution Sanofi R&D and Joel Ducassou, Head of Solution Center Sanofi R&D, in a ceremony held June 12, 2013, at the Sanofi Research & Development Center located at Vitry-sur-Seine (Val-de-Marne area).

"With SHERPA and a joint team from Informatics & Solution and Structure Design & Informatics departments' experts offering counsel in support of scientists at any time — scientists do not need to become engaged in complex, time-consuming data management activities, but rather focus full-time on R&D. The project team is very proud to be awarded for this accomplishment," said Yves Collonot, SHERPA project manager for Sanofi.

Sanofi's SHERPA service provides a generic and complete drug discovery data exchange environment for external collaboration that enables externalized multi-disciplinary teams – including scientists and representatives from information services, data management, intellectual property and alliance management – to collaborate securely in real-time. For each partnership, SHERPA offers a common data storage and collaboration solution using the cloud-based Accelrys HEOS drug research information portal.

The SHERPA service includes comprehensive end-user guidelines, contract templates, technical expertise, support and training. SHERPA allows processes to evolve over time, adapting to feedback within the collaboration. This powerful combination provides a competitive advantage for R&D teams by enabling:

  • Improved data management, quality and security via streamlined data exchange among internal teams and external partners
  • Reduced time spent managing data and fewer errors

"As organizations struggle to manage their growing externalized research networks, Sanofi's SHERPA service exemplifies the kind of creative approach companies can take to enhance collaboration and optimize their R&D efforts," said Leif Pedersen, Accelrys' senior vice president of marketing, product management and corporate development. "Through our Scientific Innovation Lifecycle Leaders Award program, Accelrys recognizes companies that are leveraging pioneering technology solutions and processes to accelerate new product innovation, speed time-to-market and increase profitability, and we're pleased to recognize our customer, Sanofi, with the first award."

"Sanofi is committed to bringing innovative new therapies to market that protect health and enhance the lives of patients; finding the right technology solutions that can help us accomplish this goal is critical," said Carlos Garcia-Echeverria, Deputy Drug Discovery & Preclinical Development, Sanofi Oncology. "We're honored to receive the Accelrys Scientific Innovation Lifecycle Leaders Award and proud of the SHERPA team for providing a secure collaboration service that is significantly enhancing our work with external partners and driving innovation."

The Accelrys Scientific Innovation Lifecycle Leaders Award recognizes those companies working to accelerate product innovations, speed time-to-market and increase profitability through technology solutions in four categories — Life Sciences Research and Development; Materials Science and Engineering; Process Management and Compliance; and Excellence in Enterprise Informatics Implementation.

About Accelrys, Inc.

Accelrys (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.25 +19.09 0.95%
NASDAQ 4,683.4070 +45.4130 0.98%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs